CareTrust REIT Inc (CTRE) is fairly valued and Sabra Healthcare REIT Inc (SBRA) is overvalued.
Against our estimates of intrinsic value, CTRE trades at the wider discount: a margin of safety of +1%, against -607% for SBRA.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 8.7% (average of 3 methods) values the shares at $37.70; the price of $37.43 is 1% below that value, and 78% of that value comes from beyond year five.
Leak Score 27/100 on 3 of 12 signals
Discounting its cash flows at 7.5% (average of 3 methods) values the shares at $2.80; the price of $19.81 is 607% above that value, and 81% of that value comes from beyond year five.
Leak Score 0/100 on 2 of 12 signals
| Metric | CTRE | SBRA |
|---|---|---|
| Verdict | Fairly valued | Overvalued |
| Price | $37.43 | $19.81 |
| Intrinsic value | $37.70 | $2.80 |
| Margin of safety | +1% | -607% |
| Leak Score | 27/100 (3/12) | 0/100 (2/12) |
| Market cap | $8.8B | $5.1B |
| Revenue growth, 5 years | 21.7% | 5.5% |
| Operating margin | 64.9% | 18.8% |
| Net margin | 62.1% | 7.6% |
| Return on equity | 9.1% | 2.4% |
| Debt to equity | 0.27 | 0.96 |
| P/E | 23.6x | 76.2x |
| Forward P/E | 22.3x | 25.9x |
| P/B | 2.0x | 1.8x |
| Dividend yield | 4.2% | 6.1% |